Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Regenerative Medicine Outcomes With Umbilical Allograft for Musculoskeletal Conditions

NCT03390920 is registered in ClinicalTrials.gov with R3 Stem Cell as lead sponsor.

NCT NCT03390920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Regenerative Medicine Outcomes With Umbilical Allograft for Musculoskeletal Conditions
Lead sponsor
R3 Stem Cell
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2022
Completion date
January 1, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative arthritis, degenerative disc disease, ligament injury, neuropathy, osteoarthritis, pelvic pain, sports injury, tendinitis